How private capital and portfolio leaders are translating GenAI into results.
Generative AI has moved beyond early experimentation. What began as pilots and proofs of concept is now evolving into something more consequential: a new lever for value creation across private capital portfolios.
For private equity and private capital leaders, the conversation has shifted decisively. The question is no longer whether GenAI will influence performance, but how it can be applied in practical, measurable ways to improve margins, accelerate growth, and strengthen decision‑making. While some organizations remain stuck in isolated experimentation, others are demonstrating that when GenAI is embedded into the operating model, it can deliver real and repeatable impact.
This article highlights where GenAI is driving results today, what differentiates successful adopters, and how private capital leaders can move from exploration to execution.
Where value is showing up first
Across portfolios, the clearest early returns from GenAI are emerging in functions where processes are standardized, data is readily available, and outcomes are easy to measure.
Finance, procurement, and IT teams are using GenAI to automate routine activities, accelerate reporting cycles, and surface insights from large volumes of information. Examples include faster financial closes, automated contract reviews, improved vendor management, and reduced IT service volumes through conversational support tools. These use cases translate directly into cost efficiency, productivity gains, and margin improvement, and can often be replicated quickly across portfolio companies.
On the commercial side, GenAI is beginning to reshape customer engagement. In customer service environments, AI‑enabled agents handle high‑volume inquiries around the clock, while human agents are supported with real‑time guidance and knowledge access. Sales and marketing teams are applying GenAI to improve lead qualification, personalize outreach, and coach performance. When these initiatives are tied to clear commercial metrics, such as conversion rates, cycle times, and retention, they can materially improve growth efficiency.
Risk, governance, and confidence to scale
As GenAI adoption increases, so does the importance of managing risk effectively. For private capital, value creation and value protection are closely linked.
GenAI introduces new considerations related to data usage, regulatory compliance, intellectual property, and cybersecurity. At the same time, it provides new tools to strengthen risk management itself. Portfolio companies are using AI‑driven capabilities to identify cyber threats earlier, improve incident response, and streamline compliance and audit activities, reducing manual effort while improving consistency.
Strong governance and responsible AI practices play a critical role in enabling scale. Clear guardrails around data access, model use, and human oversight build confidence at the board and management level, allowing organizations to move forward decisively rather than cautiously.
Improving speed across the investment lifecycle
Beyond individual portfolio companies, GenAI is also influencing how investment teams operate.
Deal teams are using GenAI to accelerate market research, synthesize performance data, and support industry analysis – compressing timelines and improving insight quality. During integration, GenAI can help identify synergies, map processes, and standardize reporting across acquired entities. For operating partners, this means earlier visibility into issues, faster prioritization, and more timely intervention.
Over time, GenAI is becoming less about isolated efficiency gains and more about increasing the speed and quality of decision‑making across diligence, integration, and exit preparation.
Turning potential into performance
GenAI is quickly becoming a baseline capability for private capital firms and their portfolio companies. Competitive advantage will not come from running more pilots, but from embedding GenAI into how value is created, managed, and scaled.
Organizations that link GenAI initiatives to core business priorities, invest in the right foundations, and apply disciplined governance are positioning themselves to unlock durable performance gains. Those that act with clarity and intent today will shape the next phase of value creation across the private capital ecosystem.
KPMG Canada supports private capital firms and portfolio companies in translating GenAI ambition into measurable results across strategy, implementation, governance, risk, and change enablement.
For a deeper look at how leading firms are operationalizing GenAI across portfolios, read the full article on KPMG.ca.
